FDA Approves Elon Musk's Neuralink to Implant Chips in Human Brains

Elon Musk's Neuralink, a brain-implant company, has been granted approval by the U.S. Food and Drug Administration (FDA) to launch its first clinical trial involving humans.

This marks an important step in the company's efforts to develop technology to help people with neurological ailments.

Neuralink was founded in 2016 to help those suffering from diseases such as paralysis and blindness by developing a brain implant technology.

Throughout 2019 and early 2021, Elon Musk predicted that human trials of this device were close to the beginning, only for the FDA to reject this application in March.


However, Neuralink has now been given permission from the FDA to proceed with their clinical study; this comes amidst lawmakers urging regulators to investigate whether there had been a mishandling of animal testing at the company before this announcement.

In response to news of their approval, Neuralink announced on Twitter that they are not yet ready for a clinical trial and that this is just one step closer towards allowing their technology to help many people.

It remains to be seen how successful these trials will be in the coming months or years ahead, but it is clear that Elon Musk's ambitions are finally beginning to take shape in reality.

Source: US News